Corinne Johnson
Stock Analyst at Goldman Sachs
(1.28)
# 3,336
Out of 4,712 analysts
7
Total ratings
50%
Success rate
-5.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corinne Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNA Avidity Biosciences | Initiates: Buy | $59 | $31.35 | +88.20% | 1 | Sep 24, 2024 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $28 → $38 | $26.63 | +42.70% | 2 | Sep 10, 2024 | |
| CGON CG Oncology | Upgrades: Buy | $43 → $50 | $28.30 | +76.68% | 3 | May 14, 2024 | |
| IMVT Immunovant | Initiates: Buy | $50 | $26.08 | +91.72% | 1 | Mar 13, 2024 |
Avidity Biosciences
Sep 24, 2024
Initiates: Buy
Price Target: $59
Current: $31.35
Upside: +88.20%
ArriVent BioPharma
Sep 10, 2024
Maintains: Buy
Price Target: $28 → $38
Current: $26.63
Upside: +42.70%
CG Oncology
May 14, 2024
Upgrades: Buy
Price Target: $43 → $50
Current: $28.30
Upside: +76.68%
Immunovant
Mar 13, 2024
Initiates: Buy
Price Target: $50
Current: $26.08
Upside: +91.72%